ShareThis Page

Federal government settled Legionnaires' disease lawsuit for $125,000

Brian Bowling
| Monday, Oct. 27, 2014, 4:42 p.m.

The federal government paid $125,000 to settle a Legionnaires' disease lawsuit brought by the son of a Marine Corps veteran, according to court documents.

Clark E. Compston, 74, of Aliquippa contracted the disease while being treated for small cell lung cancer in the VA Pittsburgh Healthcare System's University Drive hospital in September 2011, according to the lawsuit by his son, Clint Compston of Monroeville. Clark Compston died on Nov. 14, 2011.

Compston and the government reached an agreement in August but details of the settlement weren't available. U.S. District Judge Terrence McVerry on Thursday approved a motion by Compston to approve a $125,000 settlement that includes his two brothers.

More than a dozen people have filed claims against the government because of the outbreak of Legionnaires' disease, which sickened at least 22 patients from February 2011 to November 2012 at VA campuses in Oakland and O'Hara. Six of the patients died. The VA has settled at least 10 of the complaints.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.